FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Yu. M. Lopatin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Reeks:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Onderwerpen:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Online toegang:https://www.rpcardio.com/jour/article/view/1052
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items